Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 1;43(1):1-8.
doi: 10.1097/DAD.0000000000001662.

Histopathologic Spectrum of Morphea

Affiliations

Histopathologic Spectrum of Morphea

Yvonne E Chiu et al. Am J Dermatopathol. .

Abstract

Morphea is an autoimmune skin disease with protean clinical manifestations. Histologic features are similarly variable, and skin biopsies may be nondiagnostic. A single-institution retrospective cohort study was conducted. Morphea patients who had a biopsy in 2005-2015 were included, and a histopathological review was conducted by 2 pathologists. There were 51 biopsy specimens from 40 subjects. The most common histologic features were dermal sclerosis (90%), dermal thickening (78%), collagen homogenization (86%), a superficial and deep infiltrate (76%), a moderate-abundant inflammatory infiltrate (73%), and periadnexal fat loss/decreased skin appendages (71%). Twenty-four specimens were not diagnostic of morphea. In these specimens, the main clues to diagnosis included the presence of dermal sclerosis (79%), subtle collagen homogenization (75%), dermal thickening (58%), moderate-to-abundant plasma cells (50%), and perineural inflammation (50%). There were no statistically significant differences between active and inactive lesions, nor untreated and treated lesions. The histopathologic features of morphea are variable and a high proportion of biopsies are not diagnostic. Clinicians and pathologists should have a high degree of suspicion to correctly make the diagnosis of morphea.

PubMed Disclaimer

Conflict of interest statement

Y. E. Chiu received a Dermatology Foundation Career Development Award to support this research and is a past grant recipient of Novan, Inc. Lippincott CME Institute has identified and resolved all conflicts of interest concerning this educational activity.

References

    1. Saracino AM, Denton CP, Orteu CH. The molecular pathogenesis of morphoea: from genetics to future treatment targets. Br J Dermatol. 2017;177:34–46.
    1. Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol. 2006;18:606–613.
    1. Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc. 1995;70:1068–1076.
    1. Martini G, Murray KJ, Howell KJ, et al. Juvenile-onset localized scleroderma activity detection by infrared thermography. Rheumatology (Oxford). 2002;41:1178–1182.
    1. Ranosz-Janicka I, Lis-Swiety A, Skrzypek-Salamon A, et al. Detecting and quantifying activity/inflammation in localized scleroderma with thermal imaging. Skin Res Technol. 2019;25:118–123.

LinkOut - more resources